Newsfeeds - Spark Newswire

1 minute read

Watching Psychedelics Therapy Stocks COMPASS Pathways And MindMed Following Marijuana Moment Report ‘New York Lawmaker Files Bill To Legalize Medical Psilocybin Treatments, With Focus On First Responders And Veterans…’

Today, 7:39 PM

https://www.marijuanamoment.net/new-york-lawmaker-files-bill-to-legalize-medical-psilocybin-treatments-with-focus-on-first-responders-and-veterans/

CMPS

3 minute read

MindMed Names Robert Barrow As CEO & Director, Announces Management Shake-Ups

By Jelena Martinovic

Today, 7:39 PM

Psychedelic-focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) announced Tuesday that Robert Barrow has been appointed CEO and member of the board of directors.

CRLBF

2 minute read

Fintech Focus For December 13, 2021

By Renato Capelj

Today, 7:39 PM

One Big Thing In Fintech: Understanding the fundamentals of a publicly-listed company can help with making more informed investment decisions.

AXAHY

4 minute read

EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline

By Renato Capelj

Today, 7:39 PM

This past summer, Mind Medicine (MindMed) Inc (NASDAQ: MNMD), a medicine biotech in the psychedelics sector, announced the departure of co-founder and CEO J.R. Rahn.

MNMD

2 minute read

Psilera’s DMT-Derived Drug Sees Positive Results in Pre-Clinical Study

By Aaron Bry

Today, 7:39 PM

Psilera is a Florida-based biotechnology company focused on developing drugs to treat mental disorders using non-hallucinogenic derivatives from psychedelic compounds. The company is aiming to alleviate adverse effects of disorders such as anxiety, addiction and PTSD.

ATAI

2 minute read

FDA Shows Support For Development Of MindMed’s Session Monitoring System

By Jelena Martinovic

Today, 7:39 PM

Psychedelic-focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) recently met with the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) with consultation from the Center for Drug Evaluation and Research (CDER) to

MNMD

1 minute read

‘DEA Backs White House Plan To Streamline Research On Marijuana, Psychedelics And Other Schedule I Drugs’ -Marijuana Moment Report

By Benzinga Newsdesk

Today, 7:39 PM

https://www.marijuanamoment.net/dea-backs-white-house-plan-to-streamline-research-on-marijuana-psychedelics-and-other-schedule-i-drugs/

ACB

1 minute read

‘DEA Again Boosts 2022 Production Goals For Psychedelics Like Psilocybin, MDMA and DMT’ -Marijuana Moment Report

By Benzinga Newsdesk

Today, 7:39 PM

https://www.marijuanamoment.net/dea-again-boosts-2022-production-goals-for-psychedelics-like-psilocybin-mdma-and-dmt/

CMPS

4 minute read

Cannabis Movers & Shakers: Mind Medicine, Avant Brands, Delic, Agrify, Ascend Wellness, Pure Beauty

By Jelena Martinovic

Today, 7:39 PM

Mind Medicine Appoints Maria A. Oquendo To Scientific Advisory Board Psychedelic-focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) announced recently that it has tapped Maria A. Oquendo, M.D., Ph.D. to its scientific advisory board.

AAWH

1 minute read

Psychedelics Plays COMPASS Pathways, Mind Med Quiet Following Article ‘Denver City Council Considers Expanding Psilocybin Decriminalization’ -Marijuana Moment

By Benzinga Newsdesk

Today, 7:39 PM

https://www.marijuanamoment.net/denver-city-council-considers-expanding-psilocybin-decriminalization/

CMPS